Endomysial Antibodies (EMA)
This is a blood test that helps confirm coeliac disease — an immune reaction to gluten. It is a more specialised follow-up test, usually run on a separate sample once a first coeliac test comes back positive. Like all coeliac blood tests, it only means something if you are still eating gluten, and the diagnosis itself is confirmed by a specialist.
Standard CareWhat is endomysial antibodies (ema)?
Endomysial antibodies (EMA) are a serology test — a blood test that looks for antibodies (proteins made by the immune system). The "endomysium" is a thin layer of connective tissue around muscle fibres, and the EMA test detects antibodies that bind to it. In practice the EMA test is detecting the same target as the main coeliac test: it measures antibodies against tissue transglutaminase (tTG), the enzyme involved in the immune reaction of coeliac disease (a genetic autoimmune condition triggered by gluten — the protein in wheat, rye, and barley). EMA is a more specialised test than tTG-IgA. It is read by a person under a microscope rather than produced by an automated machine, which makes it labour-intensive and user-dependent, so it is less widely performed. For that reason it is generally used as a confirmatory, second-line test rather than as the first screen — for example, a positive EMA on a separate blood sample can help support a coeliac diagnosis. EMA is one of several coeliac tests your GP can use, alongside tTG-IgA, deamidated gliadin peptide (DGP), total IgA, and — for confirmation in most adults — a small-bowel biopsy.
Why is it tested?
EMA is usually ordered after a positive first-line coeliac antibody test, to add weight to the result before or alongside specialist assessment. Because it is highly specific for coeliac disease, a positive EMA strongly supports the diagnosis; because it is labour-intensive and user-dependent, it is not used as the routine first screen. In children, a positive EMA on a separate blood sample is one of the criteria that can, in some cases, support a coeliac diagnosis without a biopsy — a pathway your GP and a paediatric gastroenterologist would oversee. As with all coeliac antibody tests, the result is only valid if you have been eating a normal, gluten-containing diet. Going gluten-free beforehand can lower the antibodies and produce a falsely negative result.
Reference range (Australia)
EMA is reported as positive or negative (sometimes with a titre) rather than a single numeric cut-off, and interpretation is laboratory-dependent. The result and reference notes printed on your own laboratory report are the ones to use.
Reference intervals vary between laboratories. Always use the range printed on your own report.
What your result means
A negative EMA does not by itself rule out coeliac disease, particularly if your first-line tTG-IgA is positive or you have symptoms or a family history. No coeliac blood test is perfect, and EMA in particular is user-dependent. As with the other tests, a falsely negative result can occur if you have already started a gluten-free diet, or if you have low total IgA (since EMA, like tTG-IgA, is an IgA-based test). Your GP will weigh the EMA against your other results and your clinical picture.
A negative EMA read alongside a negative tTG-IgA, with a normal total IgA and while eating gluten, makes active coeliac disease less likely. If symptoms persist, it is worth a conversation with your GP, who considers the full picture rather than any single antibody.
A positive EMA result strongly supports coeliac disease in someone who has been eating gluten, because the test is highly specific. It is usually seen together with a positive tTG-IgA, since both detect the same underlying antibody response. Even a positive EMA is interpreted as part of the diagnostic process rather than a standalone diagnosis. In most adults, Australian practice is to confirm coeliac disease with a small-bowel biopsy arranged by a gastroenterologist. Your GP will read your EMA alongside your tTG-IgA, total IgA, and symptoms.
What can affect your result
Gluten intake is the key factor. EMA reflects an active immune response to gluten, so the test is only reliable when it is performed while you are eating a normal gluten-containing diet, which is why your GP advises continuing gluten until coeliac testing is complete. Coeliac Australia advises confirming gluten intake for accurate results; going gluten-free beforehand can lower the antibodies and cause a falsely negative result. The antibody class matters: EMA is an IgA-based test, so — like tTG-IgA — it can be falsely negative in people with low total IgA. This is one reason total IgA is measured alongside coeliac serology, and why an IgG-based test such as DGP-IgG may be used when IgA is low. The test method itself is a factor. EMA is read under a microscope and is user-dependent, which is why it is less widely performed and is generally reserved as a confirmatory test rather than a first screen. Your GP always interprets EMA together with tTG-IgA, total IgA, and your symptoms, rather than on its own.
When to act
If your EMA is positive, your GP will read it together with your tTG-IgA and total IgA and, in most adults, arrange referral to a gastroenterologist for a confirmatory small-bowel biopsy. One thing worth knowing: going gluten-free before that assessment is complete can lower the antibodies and make the diagnosis harder to establish, so your GP will guide the timing. If your EMA is negative but your first-line test was positive, or you have ongoing symptoms or a family history, your GP will decide whether further testing or specialist review is warranted. This page is general information and is not a substitute for advice from your GP.
Frequently asked questions
Test your endomysial antibodies (ema)
NATA-accredited testing. Results in 2–5 days. No GP referral required.
View Coeliac Screen